# Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin

> **NCT03907423** · NA · COMPLETED · sponsor: **Rehab Werida** · enrollment: 70 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Rosuvastatin10 mg tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03907423
- **Lead sponsor:** Rehab Werida
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2021-01-19
- **Final completion:** 2021-01-31
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03907423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03907423, "Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03907423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*